KATHERINE GAMPER: Open Payments
NPI 1124417159 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 14 payments from 7 companies in 2025. Trend: 2023 $1,221 · 2024 $232 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| ABBVIE INC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: FARXIGA, AIRSUPRA, Kerendia, BREZTRI, VRAYLAR, Ozempic, NUZYRA, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
